Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

CorMedix (CRMD) Other Non Operating Income: 2012-2025

Historic Other Non Operating Income for CorMedix (CRMD) over the last 11 years, with Sep 2025 value amounting to -$72,727.

  • CorMedix's Other Non Operating Income fell 118.24% to -$72,727 in Q3 2025 from the same period last year, while for Sep 2025 it was -$107,194, marking a year-over-year decrease of 124.73%. This contributed to the annual value of $520,000 for FY2024, which is 1893.47% up from last year.
  • As of Q3 2025, CorMedix's Other Non Operating Income stood at -$72,727, which was down 346.31% from -$16,295 recorded in Q2 2025.
  • In the past 5 years, CorMedix's Other Non Operating Income registered a high of $530,964 during Q2 2023, and its lowest value of -$72,727 during Q3 2025.
  • Moreover, its 3-year median value for Other Non Operating Income was -$10,152 (2024), whereas its average is $130,719.
  • As far as peak fluctuations go, CorMedix's Other Non Operating Income plummeted by 14,660.53% in 2021, and later surged by 4,508.71% in 2023.
  • Over the past 5 years, CorMedix's Other Non Operating Income (Quarterly) stood at -$11,066 in 2021, then soared by 1,729.11% to $180,277 in 2022, then plummeted by 126.98% to -$29,199 in 2023, then decreased by 14.13% to $20,000 in 2024, then slumped by 118.24% to -$72,727 in 2025.
  • Its Other Non Operating Income stands at -$72,727 for Q3 2025, versus -$16,295 for Q2 2025 and -$38,172 for Q1 2025.